MVI grants additional funds to Profectus BioSciences
The funds are believed to support proof-of-concept studies in non-human primates with plasmid DNA based TriGriddelivery system (TriGrid) developed by Ichor Medical Systems and recombinant vesicular stomatitis virus
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.